HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 511 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $386,406 | +10.2% | 3,340 | -2.1% | 0.01% | +7.7% |
Q2 2023 | $350,720 | -16.1% | 3,410 | -11.0% | 0.01% | -7.1% |
Q1 2023 | $418,008 | -8.0% | 3,830 | -4.1% | 0.01% | -12.5% |
Q4 2022 | $454,497 | +45.7% | 3,993 | -20.9% | 0.02% | +33.3% |
Q3 2022 | $312,000 | -22.8% | 5,048 | -0.4% | 0.01% | -14.3% |
Q2 2022 | $404,000 | -27.6% | 5,069 | -4.4% | 0.01% | -17.6% |
Q1 2022 | $558,000 | -14.3% | 5,301 | -12.3% | 0.02% | -5.6% |
Q4 2021 | $651,000 | -8.2% | 6,044 | -6.6% | 0.02% | -14.3% |
Q3 2021 | $709,000 | +5.7% | 6,470 | -9.7% | 0.02% | +5.0% |
Q2 2021 | $671,000 | -1.0% | 7,163 | -2.8% | 0.02% | -9.1% |
Q1 2021 | $678,000 | +31.9% | 7,366 | +4.8% | 0.02% | +29.4% |
Q4 2020 | $514,000 | -49.0% | 7,027 | -45.8% | 0.02% | -57.5% |
Q3 2020 | $1,007,000 | +280.0% | 12,965 | +172.3% | 0.04% | +233.3% |
Q2 2020 | $265,000 | – | 4,761 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |